Healthcare
This sector includes biotechnology, pharmaceuticals, research services, home healthcare, hospitals, long-term-care facilities, and medical equipment and supplies. Also include pharmaceutical retailers and companies which provide health information services. Companies in this sector include AstraZeneca, Pfizer, and Roche Holding, Walgreens Boots Alliance, and Cerner Corp.
Market Cap
6.438T
Market Weight
11.27%
Industries
11
Companies
1204
Healthcare S&P 500 ^GSPC
Loading Chart for Healthcare
DELL

Day Return

Sector
0.12%
S&P 500
1.57%

YTD Return

Sector
1.71%
S&P 500
5.57%

1-Year Return

Sector
2.13%
S&P 500
20.78%

3-Year Return

Sector
4.02%
S&P 500
19.57%

5-Year Return

Sector
63.13%
S&P 500
72.24%

Note: Sector performance is calculated based on the previous closing price of all sector constituents

Industries in This Sector

Select an Industry for a Visual Breakdown

Industry Market Weight Day Return YTD Return
All Industries 100% -0.12% 1.71%
Drug Manufacturers - General 34.23% 1.42% 7.81%
Healthcare Plans 13.30% -0.63% -5.72%
Medical Devices 12.90% -0.97% 3.24%
Diagnostics & Research 11.44% -1.15% 1.83%
Biotechnology 11.04% -1.03% -8.52%
Medical Instruments & Supplies 6.66% -0.68% 2.30%
Medical Care Facilities 2.92% 0.55% 9.58%
Drug Manufacturers - Specialty & Generic 2.76% 0.20% -6.17%
Medical Distribution 2.43% -0.78% 10.13%
Health Information Services 2.09% -4.07% 4.38%
Pharmaceutical Retailers 0.24% -1.44% -31.76%

Note: Percentage % data on heatmap indicates Day Return

All Industries

Largest Companies in This Sector

Name
Last Price
1Y Target Est.
Market Weight
Market Cap
Day Change %
YTD Return
Avg. Analyst Rating
781.10 826.94 11.73% 742.643B +5.95% +34.00%
Buy
483.70 566.61 7.03% 445.043B -1.09% -8.12%
Buy
144.59 173.75 5.50% 348.43B -1.52% -7.75%
Buy
129.22 141.02 5.17% 327.318B -0.69% +18.53%
Buy
162.64 183.53 4.55% 287.979B +0.69% +4.95%
Buy
568.72 619.07 3.43% 217.088B -1.42% +7.15%
Buy
105.97 126.69 2.90% 183.877B -1.21% -3.72%
Buy
246.62 271.39 2.89% 182.668B -0.08% +6.60%
Buy
273.94 306.20 2.32% 146.935B -0.88% -4.89%
Buy
25.62 31.10 2.29% 145.074B -0.08% -11.01%
Buy

Investing in the Healthcare Sector

Start Investing in the Healthcare Sector Through These ETFs and Mutual Funds

ETF Opportunities

Name
Last Price
Net Assets
Expense Ratio
YTD Return
140.33 41.319B 0.09% +2.90%
256.04 21.195B 0.10% +2.13%
126.92 7.632B 0.45% -6.57%
84.62 7.551B 0.35% -5.23%
55.01 5.76B 0.40% +1.93%

Mutual Fund Opportunities

Name
Last Price
Net Assets
Expense Ratio
YTD Return
207.37 47.432B 0.29% -0.83%
87.44 47.432B 0.29% -0.83%
128.14 21.195B 0.10% +2.17%
90.17 15.399B 0.80% +2.58%
92.74 15.399B 0.80% +5.24%

Healthcare Research

Discover the Latest Analyst and Technical Research for This Sector

  • Analyst Report: Aurora Cannabis Inc.

    Aurora Cannabis, headquartered in Edmonton, Canada, cultivates and sells medicinal and recreational cannabis through a portfolio of brands that includes Drift, San Rafael '71, Daily Special, Whistler, Being, and Greybeard. Although the company primarily operates in Canada, it has expanded internationally through medical cannabis exporting agreements.

    Rating
    Price Target
     
  • Analyst Report: Coloplast A/S

    Coloplast is a leading global competitor in ostomy management and continence care. The firm designs, manufactures, and markets ostomy care systems, disposable containment devices, paste, powder, seals, and intermittent catheters for continence care. Coloplast also maintains a tertiary presence in the urology and woundcare markets, where it manufactures and markets penile implants, slings for incontinence and prolapse, and wound dressings. The company derives more than 60% of sales from Europe, 24% from other developed countries, and 17% from the rest of the world.

    Rating
    Price Target
     
  • Analyst Report: Curaleaf Holdings, Inc.

    Curaleaf is headquartered in Wakefield, Massachusetts, and cultivates and sells medicinal and recreational cannabis in the US. The company has operations in 17 states. Its brands include Curaleaf, Select, and Grassroots. The company has made acquisitions that give it exposure to the growing European market, a unique feature among US multistate operators.

    Rating
    Price Target
     
  • Analyst Report: Cronos Group Inc.

    Cronos Group, headquartered in Toronto, Canada, cultivates and sells medicinal and recreational cannabis through its medicinal brand, Peace Naturals, and its two recreational brands, Cove and Spinach. Although it primarily operates in Canada, Cronos exports medical cannabis primarily to Israel. In the U.S. the company has an option to acquire 10.5% of U.S. multistate operator PharmaCann upon easing of federal prohibition.

    Rating
    Price Target
     

From the Community

Healthcare News